Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  28 (2024)
Volume  27 (2023)
Volume  26 (2022)
Volume  25 (2021)
Volume  24 (2020)
Volume  23 (2019)
Volume  22 (2018)
Volume  21 (2017)
Volume  20 (2016)
Volume  19 (2015)
Volume  18 (2014)
Volume  17 (2013)
Volume  16 (2012)
Volume  15 (2011)
Volume  14 (2010)
Volume  13 (2009)
Volume  12 (2008)
Volume  11 (2007)
Volume  10 (2006)
Volume  9 (2005)
Volume  8 (2004)
Related articles

VOLUME 25 , ISSUE 12 ( December, 2021 ) > List of Articles

CASE SERIES

Long Runs and Higher Incidence of Bleeding Complications in COVID-19 Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: A Case Series from the United Arab Emirates

Vivek Kakar, Anita North, Gurjyot Bajwa, Nuno Raposo, G Praveen Kumar

Keywords : Acute respiratory distress syndrome, COVID-19, Extracorporeal membrane oxygenation, SARS-CoV-2

Citation Information : Kakar V, North A, Bajwa G, Raposo N, Kumar GP. Long Runs and Higher Incidence of Bleeding Complications in COVID-19 Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: A Case Series from the United Arab Emirates. Indian J Crit Care Med 2021; 25 (12):1452-1458.

DOI: 10.5005/jp-journals-10071-24054

License: CC BY-NC 4.0

Published Online: 17-12-2021

Copyright Statement:  Copyright © 2021; The Author(s).


Abstract

Although the pathophysiology of pulmonary disease caused by coronavirus disease-2019 (COVID-19) is not yet fully understood, successful extracorporeal membrane oxygenation (ECMO) use has been reported for COVID-19-related severe acute respiratory distress syndrome (ARDS). We report a case series of 12 patients who received long venovenous ECMO (VV ECMO) runs for refractory hypoxia (median PF ratio of 71.8, interquartile range (IQR) 53.5–78.5) from COVID-19-related ARDS. A majority (75%) of the patients were males with a median age of 44 (IQR 37–53.5). Overall, six (50%) patients survived to hospital discharge with five of them (83.3%) noted to be cerebral performance category 1 or 2 at the time of discharge. Survivors consistently showed an improvement in sequential organ failure assessment scores within 72 hours of ECMO initiation. The median ECMO duration was 28 days (IQR 13.5–50). Despite using standard anticoagulation strategy, six (50%) of our patients had one or more major bleeding episodes, which proved to be directly fatal in four (25%) patients. Although the overall outcomes of our cohort were acceptable, our patients had much longer ECMO runs (mean 38 days in survivors) and with much higher, often fatal bleeding complications. We compare our data with other published COVID-19 VV ECMO series.

HTML PDF Share
  1. Ziehr DR, Alladina J, Petri CR, Maley JH, Moskowitz A, Medoff BD, et al. Respiratory pathophysiology of mechanically ventilated patients with COVID-19: a cohort study. Am J Respir Crit Care Med 2020;201(12):1560–1564. DOI: 10.1164/rccm.202004-1163LE.
  2. Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. COVID-19 does not lead to a “typical” acute respiratory distress syndrome. Am J Respir Crit Care Med 2020;201(10):1299–1300. DOI: 10.1164/rccm.202003-0817LE.
  3. Roberts CM, Levi M, McKee M, Schilling R, Lim WS, Grocott MPW. COVID-19: a complex multisystem disorder. Br J Anaesth 2020;125(3):238–242. DOI: 10.1016/j.bja.2020.06.013.
  4. Coppo A, Bellani G, Winterton D, Di Pierro M, Soria A, Faverio P, et al. Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study. Lancet Respir Med 2020;8(8):765–774. DOI: 10.1016/S2213-2600(20)30268-X.
  5. Mittermaier M, Pickerodt P, Kurth F, de Jarcy LB, Uhrig A, Garcia C, et al. Evaluation of PEEP and prone positioning in early COVID-19 ARDS. EClinicalMedicine 2020;28:100579. DOI: 10.1016/j.eclinm.2020.100579.
  6. Schmidt M, Hajage D, Lebreton G, Monsel A, Voiriot G, Levy D, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study. Lancet Respir Med 2020;8(11):1121–1131. DOI: 10.1016/S2213-2600(20)30328-3.
  7. Barbaro RP, MacLaren G, Boonstra PS, Iwashyna TJ, Slutsky AS, Fan E, et al. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry. Lancet 2020;396(10257):1071–1078. DOI: 10.1016/S0140-6736(20)32008-0.
  8. Falcoz PE, Monnier A, Puyraveau M, Perrier S, Ludes PO, Olland A, et al. Extracorporeal membrane oxygenation for critically ill patients with COVID-19-related acute respiratory distress syndrome: worth the effort? Am J Respir Crit Care Med 2020;202(3):460–463. DOI: 10.1164/rccm.202004-1370LE.
  9. Agerstrand C, Dubois R, Takeda K, Uriel N, Lemaitre P, Fried J, et al. Extracorporeal membrane oxygenation for coronavirus disease 2019: crisis standards of care. ASAIO J 2021;67(3):245–249. DOI: 10.1097/MAT.0000000000001376.
  10. Kon ZN, Smith DE, Chang SH, Goldenberg RM, Angel LF, Carillo JA, et al. Extracorporeal membrane oxygenation support in severe COVID-19. Ann Thorac Surg 2021;111(2):537–543. DOI: 10.1055/s-0040-1721487.
  11. Waite AAC, Hamilton DO, Pizzi R, Ageno W, Welters ID. Hypercoagulopathy in severe COVID-19: implications for acute care. Thromb Haemost 2020;120(12):1654–1667. DOI: 10.1055/s-0040-1721487.
  12. Sadeghipour P, Talasaz AH, Rashidi F, Sharif-Kashani B, Beigmohammadi MT, Farrokhpour M, et al. Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit: the INSPIRATION randomized clinic. JAMA 2021;325(16):1620–1630. DOI: 10.1001/jama.2021.4152.
  13. Shah A, Donovan K, McHugh A, Pandey M, Aaron L, Bradbury CA, et al. Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational study. Crit Care 2020;24(1):561. DOI: 10.1186/s13054-020-03260-3.
  14. Panagiotis Margos N, Stylianos Meintanopoulos A, Filioglou D, Ellul J. Intracerebral hemorrhage in COVID-19: a narrative review. J Clin Neurosci 2021;89:271. DOI: 10.1016/j.jocn.2021.05.019.
  15. Godier A, Clausse D, Meslin S, Bazine M, Lang E, Huche F, et al. Major bleeding complications in critically ill patients with COVID-19 pneumonia. J Thromb Thrombolysis 2021;52(1):18–21. DOI: 10.1007/s11239-021-02403-9.
  16. Combes A, Hajage D, Capellier G, Demoule A, Lavoué S, Guervilly C, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 2018;378(21):1965–1975. DOI: 10.1056/NEJMoa1800385.
  17. Extracorporeal Life Support Organization (ELSO) ELSO Registry Data Definitions. 2018. Available from: www.ELSO.org.
  18. Full COVID-19 Registry Dashboard. 2021. Available from: https://www.elso.org/Registry/FullCOVID19RegistryDashboard.aspx.
  19. Tatooles AJ, Mustafa AK, Alexander PJ, Joshi DJ, Tabachnick DR, Cross CA, et al. Extracorporeal membrane oxygenation for patients with COVID-19 in severe respiratory failure. JAMA Surg 2020;155(10):990–992. DOI: 10.1001/jamasurg.2020.3950.
  20. Arabi YM, Mandourah Y, Al-Hameed F, Sindi AA, Almekhlafi GA, Hussein MA, et al. Corticosteroid therapy for critically ill patients with middle east respiratory syndrome. Am J Respir Crit Care Med 2018;197(6):757–767. DOI: 10.1164/rccm.201706-1172OC.
  21. Lee N, Chan PKS, Hui DSC, Rainer TH, Wong E, Choi KW, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009;200(4):492–500. DOI: 10.1086/600383.
  22. RECOVERY Collaborative Group; Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2021;384(8):693–704. DOI: 10.1056/NEJMoa2021436.
  23. Schmidt M, Chommeloux J, Frere C, Hekimian G, Combes A. Overcoming bleeding events related to extracorporeal membrane oxygenation in COVID-19–authors’ reply. Lancet Respir Med 2020;8(12):e89. DOI: 10.1016/S2213-2600(20)30468-9.
  24. Zhang J, Merrick B, Correa GL, Camporota L, Retter A, Doyle A, et al. Veno-venous extracorporeal membrane oxygenation in coronavirus disease 2019: a case series. ERJ Open Res 2020;6(4):00463–2020. DOI: 10.1183/23120541.00463-2020.
  25. Fletcher-Sandersjöö A, Thelin EP, Bartek J, Broman M, Sallisalmi M, Elmi-Terander A, et al. Incidence, outcome, and predictors of intracranial hemorrhage in adult patients on extracorporeal membrane oxygenation: a systematic and narrative review. Front Neurol 2018;9:548. DOI: 10.3389/fneur.2018.00548.
  26. Luyt CE, Bréchot N, Demondion P, Jovanovic T, Hékimian G, Lebreton G, et al. Brain injury during venovenous extracorporeal membrane oxygenation. Intensive Care Med 2016;42(5):897–907. DOI: 10.1007/s00134-016-4318-3.
  27. Le Guennec L, Cholet C, Huang F, Schmidt M, Bréchot N, Hékimian G, et al. Ischemic and hemorrhagic brain injury during venoarterial-extracorporeal membrane oxygenation. Ann Intensive Care 2018;8(1):129. DOI: 10.1186/s13613-018-0475-6.
  28. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020;18(4):844–847. DOI: 10.1111/jth.14768.
  29. Paper: fibrinogen replacement underutilization in ECMO. 2021. Available from: https://ash.confex.com/ash/2020/webprogram/Paper142812.html.
  30. Zhou Z, Kang H, Li S, Zhao X. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol 2020;267(8):2179–2184. DOI: 10.1007/s00415-020-09929-7.
  31. Bermejo-Martin JF, Almansa R, Torres A, Gonzalez-Rivera M, Kelvin DJ. Covid-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction. Cardiovasc Res 2020;116(10):E132–E133. DOI: 10.1093/cvr/cvaa140.
  32. Cypel M, Keshavjee S. When to consider lung transplantation for COVID-19. Lancet Respir Med 2020;8(10):944–946. DOI: 10.1016/S0140-6736.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.